微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 43.81% | -20.81% | -3.5% | 40/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 45.4% | -18.45% | -1.03% | 42/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 45.87% | -18.2% | -16.14% | 41/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 54.7% | 7.76% | -1.14% | 40/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 55.33% | 11.53% | -0.62% | 39/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 55.67% | 14.7% | -0.72% | 39/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 56.08% | 21.91% | 10.47% | 38/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 50.76% | 3.44% | 2.32% | 39/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 49.61% | 1.82% | 2.21% | 38/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 48.54% | -0.5% | 5.51% | 38/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 46% | -4.83% | -6.27% | 38/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 49.08% | 3.26% | 0.73% | 40/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 48.72% | -0.07% | -0.12% | 39/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 48.78% | 1.74% | 0.93% | 39/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 48.33% | 1.96% | 1.69% | 34/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 47.53% | -3.78% | -2.51% | 42/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 48.75% | 1.01% | 1.68% | 39/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 47.95% | -0.18% | 1.15% | 40/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 47.4% | 2.29% | -4.03% | 31/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 49.39% | -0.92% | 2.33% | 37/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 48.27% | -1.74% | 0.48% | 32/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 48.04% | -2.17% | 3.66% | 37/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 46.34% | -6.33% | -7.05% | 26/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 49.85% | 5.67% | 1.49% | 35/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 49.12% | 1.76% | 0.05% | 23/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 49.1% | 0.09% | -0.75% | 23/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 49.47% | 1.99% | 4.87% | 19/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 47.18% | -8.7% | -2.27% | 33/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 48.27% | -9.48% | -1.59% | 21/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 49.06% | -9.68% | 1.12% | 22/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 48.51% | -6.12% | -6.12% | 19/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 51.67% | -2.64% | -3.1% | 30/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 53.33% | 4.92% | -1.81% | 18/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 54.31% | 14.45% | 5.11% | 19/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 51.67% | 32.37% | -2.64% | 18/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 53.07% | 9.22% | 4.42% | 23/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 50.83% | 0.27% | 7.1% | 17/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 47.46% | -5.32% | 21.57% | 19/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 39.04% | -18.96% | -19.67% | 17/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 48.6% | -15.75% | -4.13% | 22/55 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 50.69% | -10.78% | 1.13% | 16/55 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 50.12% | -13.12% | 4.05% | 17/55 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 48.17% | -19% | -16.49% | 13/55 | 57.69% | 我武生物 | 95.59% | 行业排名> |